Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients

S. H. Dougherty, K. R. Sirinek, P. R. Schauer, M. P. Fink, Timothy Fabian, D. H. Martin, B. Wiedermann

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Combinations of penicillins with beta-lactamase inhibitors have become acceptable treatments for mixed bacterial infections. The objective of this multicenter, randomized, open-label study was to compare the efficacy, safety, and tolerance of ticarcillin/clavulanate with clindamycin/gentamicin (with or without ampicillin) when administered to adult and pediatric patients with intra-abdominal infections. A total of 993 patients 2 years of age or older were entered in this trial if they had suspected or bacteriologically documented intra-abdominal infection. Of these, 341 were determined at the time of operation to have intra-abdominal infection. Cure rates at the time of final assessment were 79%, 80%, and 82% for ticarcillin/clavulanate, and clindamycin/gentamicin without or with ampicillin, respectively (P = 0.829, Cochran-Mantel-Haenszel). The most frequent reason for failure was development of an intra-abdominal abscess (6% of patients overall), followed by wound infections (4%), and persistent fever (3%). Two patients who had received ticarcillin/clavulanate and five who had received clindamycin/gentamicin required discontinuation of the study regimen because of adverse drug reactions. The bacteria isolated most frequently from study failures were E. coli, B. fragilis, Pseudomonas, and Streptococci. In this study, ticarcillin/clavulanate was as effective as the combination of clindamycin/gentamicin for the treatment of intra-abdominal infections.

Original languageEnglish (US)
Pages (from-to)297-303
Number of pages7
JournalAmerican Surgeon
Volume61
Issue number4
StatePublished - Jan 1 1995

Fingerprint

Ticarcillin
Intraabdominal Infections
Clavulanic Acid
Clindamycin
Ampicillin
Gentamicins
Pediatrics
Abdominal Abscess
Wound Infection
Therapeutics
Pseudomonas
Streptococcus
Drug-Related Side Effects and Adverse Reactions
Coinfection
Bacterial Infections
Penicillins
Fever
Escherichia coli
Bacteria
Safety

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Dougherty, S. H., Sirinek, K. R., Schauer, P. R., Fink, M. P., Fabian, T., Martin, D. H., & Wiedermann, B. (1995). Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients. American Surgeon, 61(4), 297-303.

Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients. / Dougherty, S. H.; Sirinek, K. R.; Schauer, P. R.; Fink, M. P.; Fabian, Timothy; Martin, D. H.; Wiedermann, B.

In: American Surgeon, Vol. 61, No. 4, 01.01.1995, p. 297-303.

Research output: Contribution to journalArticle

Dougherty, SH, Sirinek, KR, Schauer, PR, Fink, MP, Fabian, T, Martin, DH & Wiedermann, B 1995, 'Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients', American Surgeon, vol. 61, no. 4, pp. 297-303.
Dougherty, S. H. ; Sirinek, K. R. ; Schauer, P. R. ; Fink, M. P. ; Fabian, Timothy ; Martin, D. H. ; Wiedermann, B. / Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients. In: American Surgeon. 1995 ; Vol. 61, No. 4. pp. 297-303.
@article{a6efeee111e044ca8e5c3a44882a8516,
title = "Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients",
abstract = "Combinations of penicillins with beta-lactamase inhibitors have become acceptable treatments for mixed bacterial infections. The objective of this multicenter, randomized, open-label study was to compare the efficacy, safety, and tolerance of ticarcillin/clavulanate with clindamycin/gentamicin (with or without ampicillin) when administered to adult and pediatric patients with intra-abdominal infections. A total of 993 patients 2 years of age or older were entered in this trial if they had suspected or bacteriologically documented intra-abdominal infection. Of these, 341 were determined at the time of operation to have intra-abdominal infection. Cure rates at the time of final assessment were 79{\%}, 80{\%}, and 82{\%} for ticarcillin/clavulanate, and clindamycin/gentamicin without or with ampicillin, respectively (P = 0.829, Cochran-Mantel-Haenszel). The most frequent reason for failure was development of an intra-abdominal abscess (6{\%} of patients overall), followed by wound infections (4{\%}), and persistent fever (3{\%}). Two patients who had received ticarcillin/clavulanate and five who had received clindamycin/gentamicin required discontinuation of the study regimen because of adverse drug reactions. The bacteria isolated most frequently from study failures were E. coli, B. fragilis, Pseudomonas, and Streptococci. In this study, ticarcillin/clavulanate was as effective as the combination of clindamycin/gentamicin for the treatment of intra-abdominal infections.",
author = "Dougherty, {S. H.} and Sirinek, {K. R.} and Schauer, {P. R.} and Fink, {M. P.} and Timothy Fabian and Martin, {D. H.} and B. Wiedermann",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "61",
pages = "297--303",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "4",

}

TY - JOUR

T1 - Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients

AU - Dougherty, S. H.

AU - Sirinek, K. R.

AU - Schauer, P. R.

AU - Fink, M. P.

AU - Fabian, Timothy

AU - Martin, D. H.

AU - Wiedermann, B.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Combinations of penicillins with beta-lactamase inhibitors have become acceptable treatments for mixed bacterial infections. The objective of this multicenter, randomized, open-label study was to compare the efficacy, safety, and tolerance of ticarcillin/clavulanate with clindamycin/gentamicin (with or without ampicillin) when administered to adult and pediatric patients with intra-abdominal infections. A total of 993 patients 2 years of age or older were entered in this trial if they had suspected or bacteriologically documented intra-abdominal infection. Of these, 341 were determined at the time of operation to have intra-abdominal infection. Cure rates at the time of final assessment were 79%, 80%, and 82% for ticarcillin/clavulanate, and clindamycin/gentamicin without or with ampicillin, respectively (P = 0.829, Cochran-Mantel-Haenszel). The most frequent reason for failure was development of an intra-abdominal abscess (6% of patients overall), followed by wound infections (4%), and persistent fever (3%). Two patients who had received ticarcillin/clavulanate and five who had received clindamycin/gentamicin required discontinuation of the study regimen because of adverse drug reactions. The bacteria isolated most frequently from study failures were E. coli, B. fragilis, Pseudomonas, and Streptococci. In this study, ticarcillin/clavulanate was as effective as the combination of clindamycin/gentamicin for the treatment of intra-abdominal infections.

AB - Combinations of penicillins with beta-lactamase inhibitors have become acceptable treatments for mixed bacterial infections. The objective of this multicenter, randomized, open-label study was to compare the efficacy, safety, and tolerance of ticarcillin/clavulanate with clindamycin/gentamicin (with or without ampicillin) when administered to adult and pediatric patients with intra-abdominal infections. A total of 993 patients 2 years of age or older were entered in this trial if they had suspected or bacteriologically documented intra-abdominal infection. Of these, 341 were determined at the time of operation to have intra-abdominal infection. Cure rates at the time of final assessment were 79%, 80%, and 82% for ticarcillin/clavulanate, and clindamycin/gentamicin without or with ampicillin, respectively (P = 0.829, Cochran-Mantel-Haenszel). The most frequent reason for failure was development of an intra-abdominal abscess (6% of patients overall), followed by wound infections (4%), and persistent fever (3%). Two patients who had received ticarcillin/clavulanate and five who had received clindamycin/gentamicin required discontinuation of the study regimen because of adverse drug reactions. The bacteria isolated most frequently from study failures were E. coli, B. fragilis, Pseudomonas, and Streptococci. In this study, ticarcillin/clavulanate was as effective as the combination of clindamycin/gentamicin for the treatment of intra-abdominal infections.

UR - http://www.scopus.com/inward/record.url?scp=0028951415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028951415&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 297

EP - 303

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 4

ER -